MedWatch

Demant's hearing implant division struggled with recalls and pandemic pressure

From the second half of 2022, Demant will no longer sell hearing implants. The company’s implant division, Oticon Medical, has been challenged by past recalls and the pandemic situation, says CEO Søren Nielsen.

Søren Nielsen, CEO of Demant | Photo: Demant / PR

Hearing aid manufacturer Demant has just announced its intention to divest its business division that has long been outwardly signaled to be one of its strategically important areas.

Despite having previously demonstrated fine growth, the hearing implant division, which the company has invested heavily in for many years, has lately been experiencing headwinds on several fronts. As a result, Demant has decided to focus its efforts elsewhere.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs